Correlation Between Regeneron Pharmaceuticals and Oak View

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Oak View at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Oak View into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Oak View National, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Oak View and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Oak View. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Oak View.

Diversification Opportunities for Regeneron Pharmaceuticals and Oak View

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regeneron and Oak is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Oak View National in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oak View National and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Oak View. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oak View National has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Oak View go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Oak View

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Oak View. In addition to that, Regeneron Pharmaceuticals is 2.8 times more volatile than Oak View National. It trades about -0.32 of its total potential returns per unit of risk. Oak View National is currently generating about 0.25 per unit of volatility. If you would invest  1,450  in Oak View National on October 9, 2024 and sell it today you would earn a total of  40.00  from holding Oak View National or generate 2.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy95.0%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  Oak View National

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Oak View National 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Oak View National are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward-looking signals, Oak View may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Regeneron Pharmaceuticals and Oak View Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and Oak View

The main advantage of trading using opposite Regeneron Pharmaceuticals and Oak View positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Oak View can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oak View will offset losses from the drop in Oak View's long position.
The idea behind Regeneron Pharmaceuticals and Oak View National pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
CEOs Directory
Screen CEOs from public companies around the world